Page 68 - 《中国药科大学学报》2025年第5期
P. 68
600 学报 Journal of China Pharmaceutical University 2025, 56(5): 592 − 600 第 56 卷
[13]
化应激和炎症缓解肾纤维化 ,通过调节 Usp18 干 16(2): 84-96.
[4] Wynn TA. Integrating mechanisms of pulmonary fibrosis[J]. J
[14]
预心肌肥大和纤维化 ,也为解释豆蔻明跨器官的
Exp Med, 2011, 208(7): 1339-1350.
抗纤维化作用提供统一的作用范式。 [5] Schafer MJ, White TA, Iijima K, et al. Cellular senescence me-
mTOR 是一种丝氨酸/苏氨酸激酶,能调节各种 diates fibrotic pulmonary disease[J]. Nat Commun, 2017, 8:
14532.
基本细胞过程,包括蛋白质合成、生长、代谢、衰老、
[6] Daimary UD, Parama D, Rana V, et al. Emerging roles of car-
[15]
再生、自噬等 。mTOR 是 mTORC1 和 mTORC2 damonin, a multitargeted nutraceutical in the prevention and
两 种 功 能 不 同 的 多 亚 基 蛋 白 复 合 物 的 核 心 成 treatment of chronic diseases[J]. Curr Res Pharmacol Drug Dis-
cov, 2020, 2: 100008.
分 [16−17] 。mTORC1 作为豆蔻明作用的关键靶点,其
[7] Kasper M, Barth K. Bleomycin and its role in inducing apopto-
调控机制存在疾病特异性。在心脏纤维化中,豆蔻 sis and senescence in lung cells-modulating effects of caveolin-
明通过破坏 mTOR-Raptor 结合,抑制 mTORC1 复合 1[J]. Curr Cancer Drug Targets, 2009, 9(3): 341-353.
[8] Qi ZY, Yang WQ, Xue BB, et al. ROS-mediated lysosomal
体形成发挥心脏保护作用 。而在 IPF 相关成纤维
[18]
membrane permeabilization and autophagy inhibition regulate
细胞衰老模型中,发现豆蔻明主要通过抑制 mTOR bleomycin-induced cellular senescence[J]. Autophagy, 2024,
的活化,降低细胞 ROS 水平实现的缓解细胞衰老 20(9): 2000-2016.
[9] Duan JM, Duan JP, Zhang ZY, et al. Irreversible cellular senes-
的作用。这提示豆蔻明调控 mTOR 通路的具体方
cence induced by prolonged exposure to H 2 O 2 involves DNA-
式可能具有组织特异性,但其靶向 mTOR 这一核心 damage-and-repair genes and telomere shortening[J]. Int J
节点的保守性使其具备广谱抗纤维化的能力。 Biochem Cell Biol, 2005, 37(7): 1407-1420.
[10] Fu WC, Wu G. Targeting mTOR for anti-aging and anti-cancer
然而,本研究仍存在一定局限性,豆蔻明对
therapy[J]. Molecules, 2023, 28(7): 3157.
mTOR 通路的具体作用靶点,作用方式仍未完全解 [11] Zhang J, Dang LS. Therapeutic effect and mechanism of carda-
析。此外,虽然前期研究说明豆蔻明能缓解小鼠的 monin on pulmonary fibrosis[J]. Chin Mod Doc (中国现代医
生), 2024, 62(11): 82-88.
肺纤维化表型,但其对肺组织中成纤维细胞的衰老
[12] Ye ZM, Niu ZY, Li J, et al. Cardamonin inhibits silicosis devel-
水平的影响及其与纤维化进程的关系并未明确。 opment through the PI3K-AKT signaling pathway[J]. Ecotoxi-
针对上述问题,未来研究可通过蛋白质组学结合分 col Environ Saf, 2024, 285: 117067.
[13] Zhang BH, Chen ZY, Jiang ZY, et al. Nephroprotective effects
子对接技术筛选豆蔻明的直接作用靶点,并在肺纤
of cardamonin on renal ischemia reperfusion injury/UUO-in-
维化动物模型中检测成纤维细胞的衰老,以及胶原 duced renal fibrosis[J]. J Agric Food Chem, 2023, 71(36):
沉积程度,明确豆蔻明通过“抗衰老-抗纤维化”轴 13284-13303.
[14] Feng ZY, Pan LF, Qiao C, et al. Cardamonin intervenes in my-
发挥治疗作用的潜力。总之,本研究不仅探究了豆
ocardial hypertrophy progression by regulating Usp18[J]. Phy-
蔻明通过 mTOR-ROS 轴缓解细胞衰老,也为靶向 tomedicine, 2024, 134: 155970.
该通路开发缓解 IPF 的协同治疗策略提供了新的 [15] Murugan AK. mTOR: Role in cancer, metastasis and drug resis-
tance[J]. Semin Cancer Biol, 2019, 59: 92-111.
实验依据。
[16] Loewith R, Jacinto E, Wullschleger S, et al. Two TOR com-
plexes, only one of which is rapamycin sensitive, have distinct
roles in cell growth control[J]. Mol Cell, 2002, 10(3): 457-468.
References
[17] Sarbassov DD, Ali SM, Kim DH, et al. Rictor, a novel binding
[1] Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibro- partner of mTOR, defines a rapamycin-insensitive and Raptor-
sis[J]. Lancet, 2017, 389(10082): 1941-1952. independent pathway that regulates the cytoskeleton[J]. Curr
[2] Martinez FJ, Collard HR, Pardo A, et al. Idiopathic pulmonary Biol, 2004, 14(14): 1296-1302.
fibrosis[J]. Nat Rev Dis Primers, 2017, 3: 17074. [18] You W, Wu ZM, Ye F, et al. Cardamonin protects against ad-
[3] Glass DS, Grossfeld D, Renna HA, et al. Idiopathic pulmonary verse cardiac remodeling through mTORC1 inhibition in mice
fibrosis: Current and future treatment[J]. Clin Respir J, 2022, with myocardial infarction[J]. Pharmazie, 2018, 73(9): 508-512.

